These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25119844)

  • 1. Reducing central nervous system complications associated with the human immunodeficiency virus.
    Mclauchlan D; Robertson NP
    J Neurol; 2014 Sep; 261(9):1842-5. PubMed ID: 25119844
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretroviral therapy after cryptococcal meningitis.
    Hirsch HH; Wehrle-Wieland E; Battegay M
    N Engl J Med; 2014 Sep; 371(12):1166. PubMed ID: 25229931
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiretroviral therapy after cryptococcal meningitis.
    Drain PK; Moosa Y; Powderly WG
    N Engl J Med; 2014 Sep; 371(12):1165. PubMed ID: 25229930
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiretroviral therapy after cryptococcal meningitis.
    Boulware DR; Meya DB
    N Engl J Med; 2014 Sep; 371(12):1166-7. PubMed ID: 25229929
    [No Abstract]   [Full Text] [Related]  

  • 5. Delaying initiation of ART for 5 weeks improves survival in patients with HIV infection with cyrptococcal meningitis.
    Makadzange AT; Mothobi N
    Evid Based Med; 2015 Feb; 20(1):15. PubMed ID: 25358332
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions.
    Beardsley J; Le T
    Neurology; 2015 Feb; 84(6):632. PubMed ID: 25666633
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship of CPE to HIV dementia: slain by an ugly fact?
    Berger JR; Clifford DB
    Neurology; 2014 Jul; 83(2):109-10. PubMed ID: 24907235
    [No Abstract]   [Full Text] [Related]  

  • 8. Author response.
    Caniglia EC; Hernan MA;
    Neurology; 2015 Feb; 84(6):632-3. PubMed ID: 25811065
    [No Abstract]   [Full Text] [Related]  

  • 9. Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy?
    Franco-Paredes C; Chastain DB; Rodriguez-Morales AJ; Marcos LA
    Ann Clin Microbiol Antimicrob; 2017 Mar; 16(1):9. PubMed ID: 28264683
    [No Abstract]   [Full Text] [Related]  

  • 10. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.
    Boulware DR; Meya DB; Muzoora C; Rolfes MA; Huppler Hullsiek K; Musubire A; Taseera K; Nabeta HW; Schutz C; Williams DA; Rajasingham R; Rhein J; Thienemann F; Lo MW; Nielsen K; Bergemann TL; Kambugu A; Manabe YC; Janoff EN; Bohjanen PR; Meintjes G;
    N Engl J Med; 2014 Jun; 370(26):2487-98. PubMed ID: 24963568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, censoring, and intent-to-treat analysis: dangers to generalizability.
    Boulware DR
    Clin Infect Dis; 2010 Oct; 51(8):985-6; author reply 987-9. PubMed ID: 20858076
    [No Abstract]   [Full Text] [Related]  

  • 12. Cryptococcal meningitis associated with tuberculosis in HIV infected patients.
    Singh U; Aditi ; Aneja P; Kapoor BK; Singh SP; Purewal SS
    Indian J Tuberc; 2013 Jul; 60(3):180-3. PubMed ID: 24000497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.
    Sungkanuparph S; Filler SG; Chetchotisakd P; Pappas PG; Nolen TL; Manosuthi W; Anekthananon T; Morris MI; Supparatpinyo K; Kopetskie H; Kendrick AS; Johnson PC; Sobel JD; Larsen RA
    Clin Infect Dis; 2009 Sep; 49(6):931-4. PubMed ID: 19681708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature.
    Skiest DJ; Hester LJ; Hardy RD
    J Infect; 2005 Dec; 51(5):e289-97. PubMed ID: 16321643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions.
    Caniglia EC; Cain LE; Justice A; Tate J; Logan R; Sabin C; Winston A; van Sighem A; Miro JM; Podzamczer D; Olson A; Arribas JR; Moreno S; Meyer L; del Romero J; Dabis F; Bucher HC; Wandeler G; Vourli G; Skoutelis A; Lanoy E; Gasnault J; Costagliola D; Hernán MA;
    Neurology; 2014 Jul; 83(2):134-41. PubMed ID: 24907236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation of highly active antiretroviral therapy leads to cryptococcal meningitis/choroiditis in an AIDS patient.
    Chronister CL
    Optometry; 2006 Sep; 77(9):438-45. PubMed ID: 16939885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concerns regarding a randomized study of the timing of antiretroviral therapy in zimbabweans with AIDS and acute cryptococcal meningitis.
    Grant PM; Aberg JA; Zolopa AR
    Clin Infect Dis; 2010 Oct; 51(8):984-5; author reply 987-9. PubMed ID: 20858075
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV-associated central nervous system diseases in the era of combination antiretroviral therapy.
    Tan IL; McArthur JC
    Eur J Neurol; 2011 Mar; 18(3):371-2. PubMed ID: 21159069
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiretroviral treatment initiation--authors' reply.
    Nolan S; Wood E; Montaner JS
    Lancet Infect Dis; 2014 Dec; 14(12):1176-7. PubMed ID: 25455978
    [No Abstract]   [Full Text] [Related]  

  • 20. Immediate or deferred antiretroviral therapy for central nervous system opportunistic infections?
    Torok ME; Day JN; Hien TT; Farrar JJ
    AIDS; 2005 Mar; 19(5):535-6. PubMed ID: 15764862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.